Explore more publications!

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on October 6, 2025

Newsmatics Team to Speak at Mid-Atlantic MarCom Summit on AI’s Impact on News Consumption, Distribution
Dental Liners and Bases Market Set for Steady Growth, Reaching $1.99 Bn by 2030
Sterilization Technologies Market Size to Reach $5.2 Billion by 2030 | CAGR of 5.9%
OmicInsight Appoints Jae Won Kim as Co-CEO to Drive Global Strategy and Partnerships
Urinary Incontinence Devices Market to Surpass $6,179.32 Million by 2030
Western Blotting Market dynamics, drivers & restraints, key segments, competitive landscape, and future outlook
 AeHIN and SNOMED International announce collaboration agreement focused on education and awareness-building
Eagle Pharmaceuticals Announces Availability of Unaudited First Quarter 2025 Financial Statements
Ryoncil® Revenues Increase 66% in Second Quarter Post Launch
Qualigen Therapeutics (NASDAQ: QLGN) Announces Executives, Board of Directors Appointments and Auditor Transition
New Leadership to Drive Healthy Jeena Sikho's Clinical Expansion into Physiotherapy and Sleep Care
Dyne Therapeutics Announces Additional One-Year Clinical Data Demonstrating Functional Improvement from Phase 1/2 ACHIEVE Trial of Zeleciment Basivarsen (DYNE-101) for Myotonic Dystrophy Type 1 (DM1)
[2025] Sulfonic Acid Market Growing at a CAGR of 9.2% to 2031, Says AMR
RouteGenie Announces New Integration with SafeRide Health to Enhance Broker-Provider Connectivity
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
DBV Technologies Announces Sale of approximately $30 million of ADSs Through its At-The-Market (ATM) Program on Nasdaq
DBV Technologies annonce un placement d’ADS pour un montant d’environ 30 millions de Dollars US dans le cadre de son programme At-The-Market (ATM) sur le Nasdaq
Counterpart Health Expands Leadership to Accelerate Enterprise Partnerships and Regional Adoption of AI-Powered Platform Counterpart Assistant
Eisai and Biogen Announce U.S. Availability of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection Maintenance Dose for Treatment of Early Alzheimer’s Disease
Biomea Fusion Announces Proposed Public Offering of Securities

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions